Try our Advanced Search for more refined results
Life Sciences - April, 2007
105 articles
- Judge Orders Synergetics To Reply To Rival's Claim
- High Court Ruling Shakes Up Obviousness Test
- FDA Rejects Merck's Latest COX-2 Drug
- EU Court Tentatively OK's Branded Drug Resale
- Experts Praise Patent Reform, Suggest Changes
- Legality of Trademark Keyword Ads Still in Question
- Brazil Threatens To Break Merck's Efavirenz Patent
- Royal Philips Settles Defibrillator Dispute
- Lawyers Win More For Plaintiffs In Glaxo Settlement
- Dental Co. Sued For Alleged Monopolistic Practices
- EU Parliament OK's Rules For Gene Therapy Industry
- Abbott Unit Defeats Inequitable Conduct Claims
- Claim Constructions Adopted In Medtronic v. Cordis
- Becton Dickinson Licensing Deals Under Scrutiny
- Teva v. Novartis: Post-MedImmune Declaratory Judgment
- Court Dismisses Suit Over Talking Defibrillator
- Greenberg, Attorney Dispute Malpractice Suit
- Complaint Granted In Novartis Bone Drug Case
- Pepper Hamilton Welcomes Two Health Specialists
- Cardinal Health Tags $600M For Securities Settlement
- Novartis Dismisses Some Exelon Patent Claims
- Mayer Brown Advises AstraZeneca On Acquisition
- Wyeth Sues To Protect Its Best-Selling Drug
- Amgen Exec's Spouse Settles Fraud Charge
- Judge's Ruling Will Suspend Texas Vioxx Suits
- Federal Circuit Affirms Ruling On Prilosec Process
- FDA Blocks New Generic Versions Of Pfizer's Norvasc
- Loeb & Loeb Picks Up Patent Litigator
- Three Rivers Sues Rival Over Hep C Treatment
- Greenberg Traurig Hit With Malpractice Suit
- Judge Refuses To Toss Intuitive Suit Against Caltech
- Court Nixes Retaliation Claim Against St. Luke's
- Declaratory Judgment Sought Over Allergy Patent
- Google Loses Bid To Toss Trademark Case
- Former Student Associate Hits Top At Sterne Kessler
- Teva Fights For Biaxin Marketing Rights
- MedPointe Sues Apotex Over Allergy Treatments
- FDA Revitalization Bill Progresses In Senate
- Cutera Beamed By Securities Suit
- ICU To Pay Attorneys' Fees To Alaris In Patent Case
- Shareholders Sue Amgen Over Anemia Drugs
- DOJ Official Says Reverse Payments Not Illegal
- Roche's Bid For Stay Denied In HIV Technology Case
- Authorized Generics Benefit Consumers: Report
- FDA Seizes Products From Device Maker
- Patent Reform Bill Lands In House, Senate
- Senate Blocks Medicare Drug Bill
- PDL Biopharma Sues to Protect Cardene I.V.
- After Divestiture, FTC To Allow Drug Acquistion
- Maryland Backs Down In "Wal-Mart Law" Fight
- Warner Chilcott Settles Second Ovcon Case
- Texas AG Sues CVS For Dumping Customer Records
- J&J Unit, NYU Sue Abbott Over Humira
- Cell Therapeutics Pays Up In Off-Label Marketing Case
- Novozymes Wins $15M From Danish Rival
- Outstanding Women: Christina Tchen
- Ariad Sues Amgen, Wyeth Over Enbrel
- Biotech Cos. Settle Trade Secrets Spat
- Judge Tosses Vioxx Securities Suit
- Injunction Against Stryker Vacated
- Court Rules Against J&J Unit In Artificial Disc Case
- Governors Send Support For Biologic Bill
- Medicare Drug Bill Passes Senate Committee
- Antitrust Allegations Add Fire To Catheter Dispute
- Fed. Circ. Upholds Ruling Against Generic Acular
- Appeals Court Upholds Injunction On Generic Topamax
- Emerging Weapons Against Generics Competition
- Teva Targets 13th Drug Maker In Zoloft Patent Battle
- Outstanding Women: Sharon Barner
- Judge Dismisses Fosamax Case
- Outstanding Women: Amy Goodman
- Outstanding Women: Ilene Knable Gotts
- Abbott Backs Down In Kaletra Pricing Fight
- Authorized Generics In Spotlight At Senate Hearing
- Jury Awards Doctor $6.3M
- AstraZeneca Hits Sandoz With Seroquel Patent Suit
- Merck Sues To Block Generic Singulair
- Eye Surgery Rivals Settle Patent Claims For $6.5M
- Miracle Drug Or Overdose?
- Bayer Sues Teva Over Patents For Avelox
- India Begs Novartis To Drop Patent Challenge
- J&J Fires Back At Sales Rep In Overtime Pay Suit
- J&J Wins Patent Fight Over Drug Stent
- USPTO To Reissue Seasonale Patent
- Negotiating Medicare Fees Would Save $30B: Study
- Invalid Patent Correction Leads To Reversal
- Johnson & Johnson Pays $11M To End Antitrust Suit
- Outstanding Women: Patricia Meador
- Judge Certifies New Claim In Abbott Class Action
- VaxGen Receives $11M Consolation Prize
- Shareholders Target Lilly Over Zyprexa
- Pfizer's U.K. Drug Distribution Deal Draws Scutiny
- Outstanding Women: Linda Friedman
- Judge Tosses Case For Failure To Prove Scienter
- Bristol-Myers Subpoenaed Over Plavix Deal
- Drug Companies Spend Record On Lobbying
- Palomar, Alma End Light-Based Hair Removal Suit
- Senate Eyes Penn. Health Insurers' Merger
- Nellson Asks Court To Greenlight Reduced Bonuses
- N.Y. Health Provider Labels Becton Anti-Competitive
- High Court Refuses Ranbaxy's Lipitor Appeal
- Medtronic Wins Appeal In Spinal Screw Patent Suit
- Pfizer Pays $34.7M To Settle Genotropin Charges
- The Elimination Of A Patent Licensing "Safe Haven"
- Purdue, Impax Settle Oxycontin Litigation